![]() |
市場調查報告書
商品編碼
1831883
2025-2033年手術縫線市場報告(按類型、材料、應用、最終用戶和地區)Surgical Sutures Market Report by Type, Material, Application, End User, and Region 2025-2033 |
2024年,全球手術縫線市場規模達54億美元。展望未來, IMARC Group預計到2033年,市場規模將達到86億美元,2025-2033年期間的複合年成長率(CAGR)為5.06%。先進縫合材料的開發、技術的快速進步、消費者對微創手術(MIS)的偏好轉變、消費者人均收入的增加以及整容手術的蓬勃發展,都是推動市場成長的一些因素。
慢性病盛行率不斷上升
在全球範圍內,慢性病的發生率正以前所未有的速度成長,這進一步刺激了對手術縫線的需求。根據世界衛生組織 (WHO) 統計,每年約有 4,100 萬人死於非傳染性疾病,佔全球死亡人數的 74%。肥胖、糖尿病、心血管疾病和癌症的盛行率不斷上升,導致對外科手術的需求激增,進一步刺激了市場成長。根據國際糖尿病聯盟 (IDF) 的數據,到 2045 年,將有約 7.83 億人患有糖尿病。由於人口老化和生活方式改變等因素,這些疾病變得越來越普遍,對外科手術的需求也不斷增加。因此,對手術縫合線的需求也越來越大,因為手術縫合線對於術後傷口的縫合至關重要。
先進縫合材料的開發
外科縫合線市場的最新發展徹底改變了傷口閉合技術,進一步支撐了市場成長。主要市場參與者正在開發與人體更相容的現代縫合線,以最大限度地降低感染風險並促進快速癒合。例如,2023年5月,來自麻省理工學院(MIT)的一支工程師團隊開發了「智慧」縫合線,預計將接受手術的克隆氏症患者受益,並可用於藥物輸送、發炎感知和細胞療法。這些進步有助於改善患者的治療效果,並滿足外科醫生不斷變化的需求,標誌著外科護理領域的重大飛躍。
整容手術日益盛行
消費者人均收入的不斷成長,大幅提升了人們對美容的需求,進一步刺激了對整容手術的需求,而整容手術是推動市場成長的主要因素。根據國際美容整形外科學會 (ISAPS) 2020 年的數據,2019 年全球共進行了超過 2,400 萬例非手術和手術美容手術。美容手術對精準度要求極高,這進一步催生了對高品質縫合材料的需求,以達到最佳的美容效果並確保最小的疤痕。在社會壓力、媒體影響和自我提升慾望的推動下,蓬勃發展的美容產業導致外科手術數量激增。
可吸收縫合線佔據大部分市場佔有率
可吸收縫合線細分市場的發展動力源於微創外科手術需求的不斷成長,以及人們對可吸收材料的日益青睞,因為可吸收材料能夠隨著時間的推移在體內無害地分解,無需拆線。此外,技術進步推動了抗張強度、柔韌性和生物相容性增強的可吸收縫合線的開發,進一步推動了該細分市場的成長。例如,2023年5月,一種新型奈米複合塗層被開發出來,它可以抑制生物膜的形成並殺死附著的細菌,進一步應對因細菌抗藥性而導致的術後感染病例激增。根據世界衛生組織的數據,術後手術部位感染 (SSI) 影響中低收入國家約11%的患者。它們是由切口部位或切口內軟組織中生物膜的形成引起的。此外,慢性疾病和手術發病率的不斷上升,加上全球老年人口的不斷成長,正在推動市場的成長。
複絲佔業界最大佔有率
外科縫合線市場中,對柔韌性和操作性更強的縫合線的需求日益成長,尤其是在需要精確打結的精細外科手術中,這推動了多絲縫合線市場的發展。此外,製造技術的進步使得生產出抗張強度更高、組織創傷更小的多絲縫合線成為可能,從而促進了其在外科醫生中的應用。此外,全球慢性病的日益流行和外科手術數量的不斷增加,也推動了對多絲縫合線的需求,因為與單絲縫合線相比,多絲縫合線能夠更好地閉合傷口並降低感染風險。此外,由於人們越來越關注患者的舒適度和更快的術後恢復,XYZ 縫合線市場也正在經歷成長,因為多絲縫合線通常可以減少組織反應和炎症,從而改善癒合效果。
心血管手術是領先的細分市場
全球心血管疾病的發生率不斷上升,推動了外科縫線市場中心血管手術細分市場的發展,這需要增加外科手術干預措施來應對這些疾病。根據 iData Research 的數據,美國每年約有 90 萬例心血管手術,預計到 2029 年將達到 130 萬例。隨著人口老化加劇以及不健康飲食和久坐不動等生活方式因素導致心血管疾病激增,對有效縫合材料的需求也日益增加,以確保最佳的傷口閉合和患者的康復。此外,包括微創手術在內的外科技術的進步,也推動了對專用縫合線的需求,這些縫合線旨在承受心血管手術特有的挑戰,例如縫合線的高張力和持續壓力。
醫院和診所在市場上佔據明顯主導地位
醫院業務板塊的驅動力來自於全球外科手術數量的成長,這主要源於肥胖症和其他慢性疾病患病率的上升、人口老化以及醫療基礎設施的不斷擴張。世界衛生組織的數據顯示,超過43%的18歲以上成年人超重,16%患有肥胖症。醫院需要具有優異抗張強度、打結安全性和生物相容性的外科縫合線,以確保最佳的傷口閉合效果並最大限度地減少術後併發症。此外,隨著外科技術的進步和微創手術的普及,需要能夠精確縫合組織並促進更快恢復的專用縫線。根據美國國家醫學圖書館的數據,2017年共進行了約980萬例住院手術,其中約11.1%為微創手術,2.5%為機器人輔助手術。
北美引領市場,佔據最大的手術縫合線市場佔有率
該報告還對所有主要區域市場進行了全面分析,包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告指出,北美是最大的外科縫線區域市場。
北美外科縫合線市場的成長得益於醫療保健支出的快速成長、主要市場參與者的加入以及事故數量的上升。美國和加拿大的存在也為該地區提供了支持。美國擁有多家領先的外科縫線公司,如史賽克公司、美敦力公司、波士頓科學公司、愛惜康公司、捷邁邦美控股公司、泰利福公司等。根據美國醫院協會 (AHA) 的數據,美國約有 6,090 家醫院。業內消息人士也顯示,美國每年估計進行 4,830 萬例非手術和手術。除了結腸和腸道切除術之外,皮膚腫瘤切除、膽囊和膽道治療、疝氣修補術是一般外科醫生最常進行的外科手術。
The global surgical sutures market size reached USD 5.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.06% during 2025-2033. Development of advanced suture materials, rapid technological advancements, shifting consumer preference towards minimally invasive surgeries (MIS), inflating consumer per capita income, and burgeoning prevalence of cosmetic surgeries are some of the factors bolstering the market growth.
Escalating chronic diseases prevalence
Globally, the prevalence of chronic diseases in increasing at an unprecedented rate, which has further burgeoned the demand for surgical sutures. As pe the World Health Organization (WHO), about 41 million people die of non-communicable diseases every year, which is equivalent to 74% of all the deaths globally. The escalating prevalence of obesity, diabetes, cardiovascular ailments, and cancers have surged the requirement for surgical interventions, which is further stimulating the market growth. As per the International Diabetes Federation (IDF), by 2045, about 783 million people will be living with diabetes. As these conditions become more common due to factors like aging populations and lifestyle changes, the demand for surgical procedures escalates. Consequently, there's a heightened need for surgical sutures, essential for closing wounds post-surgery.
Development of advanced suture materials
Recent developments in the surgical sutures market have completely changed the wound closure techniques, which is further supporting the market growth. Key market players are developing modern sutures that are more compatible with the human body in order to minimize the risk of infection and promote fast healing. For instance, in May 2023, a team of engineers from the Massachusetts Institute of Technology (MIT) developed "smart" sutures with the potential to benefit Crohn's disease patients undergoing surgery, and could also have applications for drug delivery, sensing inflammation, and cell therapies. These advancements help to improve patient outcomes and also cater to the evolving needs of surgeons, marking a significant leap forward in surgical care.
Burgeoning prevalence of cosmetic surgeries
The inflating consumer per capita income has considerably surged the need to seek aesthetic enhancements, further boosting the demand for cosmetic surgeries, which represents the primary factor propelling the market growth. As per the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, over 24 million non-surgical and surgical aesthetic procedures were performed globally in 2019. Aesthetic procedures require most precision, which has further burgeoned the requirement for high-quality suture materials to optimal aesthetic outcomes and ensure minimal scarring. The burgeoning cosmetic industry, fueled by societal pressures, media influence, and the desire for self-improvement, has led to a surge in surgical interventions.
Absorbable sutures accounts for the majority of the market share
The absorbable sutures segment is driven by the increasing demand for minimally invasive surgical procedures and the rising preference for absorbable materials due to their ability to break down harmlessly in the body over time, eliminating the need for suture removal. Additionally, advancements in technology leading to the development of absorbable sutures with enhanced tensile strength, flexibility, and biocompatibility further fuel the growth of this segment. For instance, in May 2023, a new nanocomposite coating was developed that can inhibit biofilm formation and also kill attached bacteria, further tackling the surging cases of post-operative infections, caused due to antibiotic resistance in bacteria. As per the WHO, post-operative surgical site infections (SSIs) affect about 11% of patients in low and middle-income countries. They are caused due to the development of biofilms on the incision site or in the soft tissue inside the site. Moreover, the growing incidence of chronic diseases and surgeries, coupled with the expanding geriatric population globally, are propelling the market growth.
Multifilament holds the largest share of the industry
The multifilament segment in the surgical sutures market is driven by the increasing demand for sutures with enhanced flexibility and handling characteristics, particularly in delicate surgical procedures where precise knot tying is essential. Additionally, advancements in manufacturing technologies have allowed for the production of multifilament sutures with improved tensile strength and reduced tissue trauma, thereby boosting their adoption among surgeons. Moreover, the growing prevalence of chronic diseases and the rising number of surgical procedures worldwide are propelling the demand for multifilament sutures, as they offer better wound closure and reduced risk of infection compared to monofilament alternatives. Furthermore, the XYZ segment is witnessing growth due to the escalating focus on patient comfort and faster postoperative recovery, as multifilament sutures are often associated with reduced tissue reaction and inflammation, leading to improved healing outcomes.
Cardiovascular Surgeries represents the leading market segment
The cardiovascular surgeries segment in the surgical sutures market is driven by the increasing prevalence of cardiovascular diseases globally, necessitating a rise in surgical interventions to address these conditions. As per the iData Research, about 900,000 cardiovascular procedures were carried out each year in the United States, and the number is projected to reach 1.3 million by 2029. With the growing aging population and lifestyle factors such as unhealthy diets and sedentary lifestyles contributing to the surge in cardiovascular issues, there's a heightened demand for effective suturing materials to ensure optimal wound closure and patient recovery. Additionally, advancements in surgical techniques, including minimally invasive procedures, are fueling the demand for specialized sutures designed to withstand the unique challenges of cardiovascular surgeries, such as high tension and continuous stress on the sutures.
Hospitals and clinics exhibits a clear dominance in the market
The hospitals segment is driven by the increasing volume of surgical procedures performed globally, spurred by rising prevalence of obesity and other chronic diseases, aging population, and expanding healthcare infrastructure. As per the WHO, over 43% of adults aged 18 and above were overweight and 16% were living with obesity. Hospitals demand surgical sutures characterized by superior tensile strength, knot security, and biocompatibility to ensure optimal wound closure and minimize post-operative complications. Moreover, advancements in surgical techniques and the adoption of minimally invasive procedures necessitate specialized sutures that enable precise tissue approximation and facilitate faster recovery. As per the National Library of Medicine, in 2017 about 9.8 million inpatient operating room procedures were conducted, from which about 11.1% of these procedures were minimally invasive and 2.5% were robotic-assisted.
North America leads the market, accounting for the largest surgical sutures market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical sutures.
The North America surgical sutures market growth is driven by the burgeoning healthcare expenditure, presence of key market players, and the rising cases of accidents. The region is also backed by the presence of the United States and Canada. The United States has a robust presence of several leading surgical suture companies, such as Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Ethicon Inc, Zimmer Biomet Holdings Inc, Teleflex Incorporated, and others. As per the American Hospital Association (AHA), the country has around 6,090 hospitals. Industry sources also show that every year, an estimated 48.3 million non-surgical and surgical procedures are performed in the United States. Skin tumor excision, gallbladder and biliary tree treatments, and hernia repairs, in addition to colon and intestine resections, are some of the most common surgical procedures performed by general surgeons.